Home
Search

Letters, Testimony & Comments

BIO submits letters, testimony, and comments to government and regulatory bodies throughout the United States and around the world.

Featured Letters, Testimony, & Comments
Testimony of John F. Crowley President and CEO,…
Chairman Griffith, Chairman Guthrie, Ranking Member DeGette, Ranking Member Pallone, and distinguished members of the subcommittee, thank you for the opportunity to appear before you today on behalf of the Biotechnology Innovation Organization (BIO)…
Learn more
CSBA Letter to Congressional Leaders on PBM, PPRV…
Dear Congressional Leaders:On behalf of the Council of State Bioscience Associations (CSBA)—a national coalition of independent, state and territory-based organizations representing the full breadth of America’s biotechnology ecosystem—we write to…
Learn more
BIO's Comments on Advisory Committee on…
Re: Docket No. CDC-2025-0783; Advisory Committee on Immunization Practices (ACIP) MeetingDear Dr. Zadeh and Members of the ACIP:The Biotechnology Innovation Organization (BIO) appreciates the opportunity to provide comments to the Advisory Committee…
Learn more
All Letters, Testimony & Comments
  • Show All
Search
Results
BIO Submits Comments to FTC on PBM Business Practices
May 5, 2022
We are writing on behalf of the Biotechnology Innovation Organization (BIO) to provide comments on the Federal Trade Commission’s (FTC’s or the Commission’s) Solicitation for Public Comments on the Business Practices of Pharmacy Benefit Managers and…
BIO Letter to Senate Appropriations Committee on Priorities for Fiscal Year 2023 Labor, Health and Human Services, Education and Related Agencies Appropriations Act
May 4, 2022
The Biotechnology Innovation Organization (BIO) is the largest biotechnology trade association, representing approximately 1,000 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United…
BIO Letter to Senate Appropriations Committee on Priorities for Fiscal Year 2023 Interior, Environment, and Related Agencies Appropriations Act
May 4, 2022
The value of science and agricultural innovation cannot be understated. The adoption of biotechnology in agriculture and the development of biobased technologies contribute to food security, sustainability, and climate change solutions. Over the…
BIO Letter to Senate Appropriations Committee on Priorities for Fiscal Year 2023 Energy and Water Development and Related Agencies Appropriations Act
May 4, 2022
Industrial biotechnology is enabling a dramatic paradigm shift in the production of fuels and chemicals. Modern biorefineries are converting domestic sources of renewable biomass, wastes, and residues into sustainable low carbon fuels, chemicals,…
BIO Letter to Senate on Key Priorities for Fiscal Year 2023 Agriculture, Rural Development, FDA and Related Agencies Appropriations Act
May 4, 2022
BIO supports public policies centered on innovation to incentivize the adoption of cutting-edge technologies and practices to maintain America’s leadership and benefit our rural economies. Further, it is crucial that the government establish risk…
BIO Letter to House Appropriations Committee on Priorities for Fiscal Year 2023 Interior, Environment, and Related Agencies Appropriations Act
April 28, 2022
BIO supports public policies centered on innovation to incentivize the adoption of cutting-edge technologies and practices and benefit rural economies. Further, it is crucial that the government establishes risk-proportionate, transparent…
BIO Letter to House Appropriations Committee on Priorities for Fiscal Year 2023 Energy and Water Development and Related Agencies Appropriations Act
April 28, 2022
The Biotechnology Innovation Organization (BIO) is the largest biotechnology trade association, representing approximately 1,000 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United…
BIO Letter to House Appropriations Committee on Priorities for Fiscal Year 2023 Labor, Health and Human Services, Education and Related Agencies Appropriations Act
April 28, 2022
The Biotechnology Innovation Organization (BIO) is the largest biotechnology trade association, representing approximately 1,000 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United…
BIO Letter to House on Key Priorities for Fiscal Year 2023 Agriculture, Rural Development, FDA and Related Agencies Appropriations Act
April 28, 2022
BIO represents 1,000 members in a biotech ecosystem with a central mission – to advance public policy that supports a wide range of companies and academic research centers that are working to apply biology and technology in the energy, agriculture,…
BIO Comments on Upcoming ODAC Pediatric Oncology Subcommittee Meeting
April 27, 2022
On Wednesday, April 27th, BIO submitted comments regarding an upcoming meeting of ODAC’s Pediatric Oncology Subcommittee on PREA Waivers for Same-in-Class Drugs. In particular, the subcommittee will meet to discuss the development of a conceptual…